Evidence map›Paper›PMID 36267783›Full record

ArticleAnnals of translational medicine2022

Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare.

Amos Lal, Johnny Dang, Christoph Nabzdyk, Ognjen Gajic, Vitaly Herasevich

Abstract readEditorialComment
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. A survey on ethical digital twins in healthcare.Frontiers in artificial intelligence · 2026
    Review
  4. Review
  5. Review
  6. Enhancing randomized clinical trials with digital twins.NPJ systems biology and applications · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Amos LalDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Johnny DangDepartment of Neurology, Cleveland Clinic Foundation, Cleveland, OH, USA.
Christoph NabzdykDivision of Critical Care, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
Ognjen GajicDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Vitaly HerasevichDivision of Critical Care, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002377
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36267783
PMCPMC9577733

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.